Pain Management Devices Market: Growth, Size, Share, and Trends

Report Code MD 4371
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Pain Management Devices Market by Type (Neurostimulation, Infusion Pump, Ablation), Application (Neuropathic, Musculoskeletal, Cancer pain), Mode of Purchase (Prescription, OTC), By End user (Hospital, Physiotherapy, Home care) - Global Forecast to 2029

Market Growth Outlook Summary

The global pain management devices market growth forecasted to transform from US$ 3,768.6 million in 2024 to US$ 5,835.8 million by 2029, driven by a CAGR of 9.1%. The global upsurge in prevalence of chronic pain conditions, growth in geriatric populations, home care preference, favourable reimbursement scenario to improve the access of pain management devices, rising technological advancements and new product launches by key players are anticipated to propel the market growth during the forecast period. However, increasing product recalls and high procedural cost become barriers to growth of pain management devices among healthcare providers and patients. Additionally, stringent regulatory requirements and use of pain medication as first line treatment option pose a significant challenge to market players.

Pain Management Devices Market – Global Forecast and Growth Insights to 2029

Pain Management Devices Market – Global Forecast and Key Opportunities to 2029

North America

Market growth in North America can be attributed to rising patient pool with chronic pain conditions favorable reimbursement policy, large presence of potential companies.

The growth of this market can be attributed to the increasing prevalence of chronic disease, technological advancements, new product launches, and emphasis on improved patient care.

Increased preference of pain management devices over conventional medications, growing home care preference among patients , rising focus on advanced pain management devices and opportunities in emerging economies are likely to promote significant growth opportunity of the market

North America dominates the pain management devices market. This market is projected to reach USD 2.92 billion by 2029, at a CAGR of 9.3% during the forecast period.

Asia Pacific is the fastest-growing regional market for pain management devices products, with China and India emerging as major growth hotspots.

Pain Management Devices Market Dynamics to 2029

DRIVER: Hike in Chronic Pain Prevalence

Chronic pain, including neck, head, and low back pain, is the leading cause of disability worldwide. The increasing instances of chronic pain conditions are anticipated to spur the global market for pain management devices. Chronic pain conditions are increasingly common as the population ages. Neuropathic pain is one form of chronic pain that is particularly severe. As per an article published by Scientific Reports 2024, nearly 1.5 billion of the global population suffer from chronic pain, with prevalence increasing with demographics, including age. Also, US Pain Foundation states, neuropathic pain was ranked as the topmost cause of pains in United States in 2021 with the prevalence of 6.9–10%. Therefore, high levels of pain-related ailments will increase demand for pain management devices in future. Additionally, recognition of chronic pain conditions along with technological advancements have led to innovative solutions in the form of neuromodulation devices and wearables. Changes in personalized medicine are making treatments more effective. Furthermore, the focus on non-opioid alternatives allows for reducing dependence on opioids. Integrating these devices into comprehensive healthcare programs also increases usability. All of these factors constitute a promising landscape for pain management devices.

RESTRAINT: Product Recalls

Pain managing devices recalls can be a serious problem because they usually deal with devices or medicines that are critical to patient care. The reasons for product recall may include; manufacturing defects, safety issues or regulatory non-compliance. Critical fluids, neurostimulations, and ablation—which may entail the use of high-risk drugs—are delivered via pain management devices. When these technologies are used incorrectly, patients may suffer severe injuries or even pass away. The primary reason for these recalls was the potential health risks associated with using these products.Keeping informed about these recalls is essential for healthcare providers and patients to ensure the safety and effectiveness of pain management solutions. Various batches of pain management devices were recently recalled by the USFDA. For example, in 2023, after receiving reports about many injured persons, FDA invited Class I recall over two types of implantable neurostimulators due to technical malfunctioning which also includes Abbott’s Proclaim (used for pain relief) has been withdrawn from use, primarily aimed at spinal cord stimulation. These things might slow down new products introduction and uptake of pain management devices.

 

OPPORTUNITY: High Growth Opportunities in Emerging Markets

China, India, and Brazil as emerging economies have significant potential to grow for pain management devices market participants. For instance, the cost of healthcare is rising dramatically in China and India, especially when it comes to medical devices. Significant investments in medical technology are being made in China as a result of the country's aging population and growing demand for sophisticated pain management techniques. In a similar vein, as demand for improved healthcare infrastructure and knowledge of chronic pain issues rise, India is seeing a spike in healthcare spending. In order to enhance quality of life, both nations are placing a high priority on pain management, which has created a thriving market for innovative devices and treatments. This pattern indicates a more general dedication to improving healthcare systems and meeting the requirements of individuals with chronic pain. Besides, upcoming years are likely to witness infrastructural progress in healthcare facilities with budgets going up while the emerging countries (especially within Asia Pacific) providing a competitive edge through low production costs should serve as a motivation for market players expecting investment within this region.

CHALLENGES: Stringent Regulatory Requirements

Strict regulations can be a challenge for manufacturers or companies who produce devices for controlling pain because they act as road blocks. They are vital in making sure that drugs or devices meant for use in controlling pain are safe and efficient but they tend to delay entry of such products into the market leading to increment in prices and addition of more paper work especially when it comes to smaller firms. In the past century, the regulatory guidelines for approved pain management devices have been tightened up in an attempt to limit errors from what has happened in several instances of medication errors involving infusion pumps. In this regard, the FDA and MHRA initiated the Infusion Pump Improvement Initiative, requiring the design validation data for manufacturers to gain premarket approval. This has made the development and commercialization process of new infusion pumps more time-consuming and costly. Regardless of the challenges associated with them, the stringent guidelines have been enacted in order to protect patients so that they are able to have access only to appropriate and secured pain relief alternatives.

Pain Management Devices Market Map & Ecosystem Overview

The pain management devices market encompasses a range of technologies aimed at alleviating pain through various ways such as ablation, infusion pumps and neurostimulation. Medical device companies are the principal participants in this sector while FDA and EMA keep a check on them. Application areas include chronic and acute pain relief including cancer-related pains with customers being health care providers, patients and R&D centers. The market is changing owing to advancements in technology with more emphasis being put on individualized pain management options.

Pain Management Devices Market Map & Ecosystem Overview
 

Neurostimulation devices held the largest market share of pain management devices in 2023

Based on type, the neurostimulation devices segment held the largest share of the pain management devices market. Also, it is fastest growing segment due to the large number of ongoing clinical studies to establish the efficacy and safety of these devices in pain management, new product launches & approvals and the increasing prevalence of chronic pain conditions. In addition, these techniques, like spinal cord stimulation and peripheral nerve stimulation, have shown real effectiveness in helping people with chronic pain conditions such as neuropathic pain and fibromyalgia. Many patients report significant relief, allowing them to enjoy a better quality of life. Another appealing aspect is that these procedures are often minimally invasive, meaning they require less recovery time and pose fewer risks than traditional surgeries. With the growing concern over opioid use and its potential for addiction, many patients and healthcare providers are actively looking for safer alternatives. Neurostimulation offers a non-drug option that can effectively manage pain without those risks, the advantages of neurostimulation as compared to alternative therapies for managing chronic pain are further propelling its market growth. Their advantages have boosted the adoption of pain management devices.

Home care settings will grow at a significant rate from 2024 to 2029 in the end-user market

Based on the end user, the pain management devices market has been classified into hospitals & clinics, physiotherapy centers ,home care settings and other end users. The market for pain management devices was dominated in 2023 by the hospitals & clinics while homecare settings registered a higher growth rate. As chronic diseases become more prevalent and the population ages, reduced hospital stays, ease and convenience at home, advancements in technology, and favorable reimbursement structures are supporting the growth of this segment. Since many patients prefer the comfort and privacy of managing their pain at home rather than frequently visiting healthcare facilities. This convenience allows them to maintain their daily routines and reduces the stress associated with hospital visits. Moreover, recent innovations have produced user-friendly, portable pain management devices that are easy to operate. These advancements make it simpler for individuals to use devices like transcutaneous electrical nerve stimulation (TENS) units or wearable pain relief gadgets in the comfort of their homes.The homecare solutions often reduce healthcare costs associated with repeated hospital visits and prolonged stays. All these are the main factors contributing to the rapid growth of home care settings in the pain management devices market.

North America accounted for the largest share of the pain management devices market in 2023

North America is forecasted to be the biggest region in the market for pain management devices over the forecast period. Growth in the pain management devices market in North America could be attributed to various factors such as the presence of favorable reimbursement options, greater public awareness regarding new technologies for pain management devices, supportive government initiatives as well as increased affordability and per capita healthcare expenditure, and many other international leading companies such as Abbott Laboratories (US), Becton Dickinson and Company (US). They have robust research environments, leading to continuous innovation in pain management solutions. This focus on R&D results in a wide range of effective devices that attract healthcare providers and patients. Also, these regions benefit from well-established healthcare systems with access to cutting-edge medical technologies. This infrastructure supports the timely availability and adoption of innovative pain management devices. In addition, an aging demographic in these regions is likely to experience more chronic pain conditions, driving demand for effective pain management solutions. This trend ensures a sustained market for pain management devices. These factors are boosting the growing demand of pain management devices in this region.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION
Pain Management Devices Market by Region – Forecast to 2029

Pain Management Devices Market Recent Developments and Insights

  • In April 2024, Medtronic (Ireland) received FDA approval for its Inceptive closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain.
  • In November2023, Boston Scientific Corporation (US) acquired Relievant Medsystems which offers Intracept Intraosseous Nerve Ablation System. This deal will be an addition to Boston’s chronic pain portfolio.
  • In June 2023, Avanos Medical, Inc. (US) acquired Diros Technology Inc., to enhance Avanos’ pain management treatment options.
  • In October 2022, Nevro Corp.(US) received FDA Approval of HFX iQ Spinal Cord Stimulation System for Personalize the Treatment of Chronic Pain. Senza HFX iQ is the first and only Artificial Intelligence-based SCS.

Pain Management Devices Market – Leading Key Players Analysis

Want to explore hidden markets that can drive new revenue in Pain Management Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million/Billion)
Segments covered Type, Application, Mode Of Purchase, End User, and Region
Geographies covered North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA (GCC Countries, RoMEA)

Key Questions Addressed by the Report

Key players in the global pain management devices market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), Stryker (US), Nevro Corp. (US), and B. Braun SE (Germany), among others.
The neurostimulation devices segment held the largest market share, driven by clinical studies, new product approvals, and the growing prevalence of chronic pain conditions.
North America dominates the market, attributed to a significant patient population, the presence of key market players, and favorable reimbursement policies.
The global pain management devices market is projected to grow from USD 3,768.6 million in 2024 to USD 5,835.8 million by 2029, at a CAGR of 9.1%.
Key growth factors include the rising prevalence of chronic pain conditions, growing geriatric population, technological advancements, home care preferences, and favorable reimbursement scenarios.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pain Management Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
32
EXECUTIVE SUMMARY
43
PREMIUM INSIGHTS
48
MARKET OVERVIEW
51
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Surge in demand for at-home pain management devices
    - Increase in surgical procedures
    - Prevalence of chronic pain conditions
    - Favorable reimbursement policies for spinal cord stimulation devices
    - Growing launches and regulatory approvals for advanced pain management devices
    RESTRAINTS
    - Rise in product recalls
    - High procedural and purchase cost of pain management devices
    OPPORTUNITIES
    - Untapped growth potential in emerging economies
    - Expansion of pain management clinics
    CHALLENGES
    - Use of pain medication as first line of treatment
    - Stringent regulatory norms for FDA approval
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Wearable devices
    - Implantable pumps
    COMPLEMENTARY TECHNOLOGIES
    - Virtual reality
    - Digital therapeutics
    ADJACENT TECHNOLOGIES
    - Robotics
  • 5.4 INDUSTRY TRENDS
    ELECTROTHERAPY DEVICES
    RECHARGEABLE SPINAL CORD STIMULATORS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TRADE ANALYSIS
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT FROM NEW ENTRANTS
    THREAT FROM SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY LANDSCAPE
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - China
    - India
    LATIN AMERICA
    - Brazil
    - Mexico
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PATENT ANALYSIS
  • 5.10 PRICING ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 REIMBURSEMENT ANALYSIS
  • 5.16 UNMET NEEDS IN PAIN MANAGEMENT DEVICES MARKET
  • 5.17 VALUE CHAIN ANALYSIS
  • 5.18 END USER EXPECTATIONS IN PAIN MANAGEMENT DEVICES MARKET
  • 5.19 IMPACT OF AI/GEN AI IN PAIN MANAGEMENT DEVICES MARKET
  • 5.20 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.21 INVESTMENT AND FUNDING SCENARIO
PAIN MANAGEMENT DEVICES MARKET, BY TYPE
95
  • 6.1 INTRODUCTION
  • 6.2 NEUROSTIMULATION DEVICES
    TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
    - Surge in demand for non-invasive therapy to drive market
    SPINAL CORD STIMULATORS
    - Extensive use of SCS for pain treatment to drive market
    OTHERS
  • 6.3 INFUSION PUMPS
    INTRATHECAL INFUSION PUMPS
    - Increasing incidences of chronic pain to drive market
    EXTERNAL INFUSION PUMPS
    - Availability of reimbursement to drive market
  • 6.4 ABLATION DEVICES
    RADIOFREQUENCY ABLATION DEVICES
    - Low cost of RF ablation procedures to drive market
    CRYOABLATION ABLATION DEVICES
    - Successful clinical trials to drive market
    ULTRASOUND ABLATION DEVICES
    - Efficacy in targeted pain management to drive market
    OTHERS
PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION
119
  • 7.1 INTRODUCTION
  • 7.2 NEUROPATHIC PAIN
    HIGH EFFICACY OF PAIN MANAGEMENT DEVICES IN NEUROPATHIC PAIN TREATMENT TO DRIVE MARKET
  • 7.3 MUSCULOSKELETAL PAIN
    SURGE IN AGING POPULATION TO DRIVE MARKET
  • 7.4 CANCER PAIN
    PREVALENCE OF CANCER TO DRIVE MARKET
  • 7.5 FACIAL PAIN & MIGRAINE
    INTRODUCTION OF NOVEL PAIN MANAGEMENT DEVICES TO DRIVE MARKET
  • 7.6 OTHER APPLICATIONS
PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE
129
  • 8.1 INTRODUCTION
  • 8.2 PRESCRIPTION-BASED
    INCREASING INCIDENCES OF MEDICAL DISORDERS TO DRIVE MARKET
  • 8.3 OVER-THE-COUNTER
    ACCESSIBILITY OF OTC PAIN MANAGEMENT DEVICES TO DRIVE MARKET
PAIN MANAGEMENT DEVICES MARKET, BY END USER
134
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & CLINICS
  • 9.3 PHYSIOTHERAPY CENTERS
    RISE OF SPORTS INJURIES AND MUSCULOSKELETAL DISORDERS TO DRIVE MARKET
  • 9.4 HOME CARE SETTINGS
    HIGH COST OF HOSPITALIZATION TO DRIVE MARKET
  • 9.5 OTHER END USERS
PAIN MANAGEMENT DEVICES MARKET, BY REGION
142
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK
    US
    - Favorable reimbursement policies to drive market
    CANADA
    - Increasing incidences of chronic pain to drive market
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK
    GERMANY
    - Robust healthcare infrastructure to drive market
    FRANCE
    - Government initiatives for lowering healthcare costs to drive market
    UK
    - Shift toward home care settings to drive market
    ITALY
    - Growing healthcare investments to drive market
    SPAIN
    - Surge in new cancer cases to drive market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK
    JAPAN
    - Large geriatric population to drive market
    CHINA
    - Growing investments in healthcare infrastructure development to drive market
    INDIA
    - High prevalence of lifestyle diseases to drive market
    AUSTRALIA
    - Initiatives promoting development of novel pain management devices to drive market
    SOUTH KOREA
    - Growing demand for effective treatment options to drive market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK
    BRAZIL
    - Private and government sector awareness programs to drive market
    MEXICO
    - Domestic health coverage schemes to drive market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - High healthcare spending capacity to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
219
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024
  • 11.3 REVENUE ANALYSIS, 2021–2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
    - Company footprint
    - Type footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 11.7 BRAND/PRODUCT COMPARISON
  • 11.8 R&D ASSESSMENT
  • 11.9 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.10 COMPETITIVE SCENARIO
    PRODUCT APPROVALS/LAUNCHES
    DEALS
    EXPANSIONS
    OTHERS
COMPANY PROFILES
236
  • 12.1 KEY PLAYERS
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT LABORATORIES
    - Business overview
    - Product offered
    - Recent developments
    - MnM view
    NEVRO CORP.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    STRYKER
    - Business overview
    - Products offered
    - Recent developments
    B. BRAUN SE
    - Business overview
    - Products offered
    - Recent developments
    BAXTER
    - Business overview
    - Products offered
    OMRON CORPORATION
    - Business overview
    - Products offered
    AVANOS MEDICAL, INC.
    - Business overview
    - Products offered
    TELEFLEX INCORPORATED
    - Business overview
    - Products offered
    ICU MEDICAL, INC.
    - Business overview
    - Products offered
    - Recent developments
    NIPRO
    - Business overview
    - Products offered
    - Recent developments
    MOOG INC.
    - Business overview
    - Products offered
    ATRICURE, INC.
    - Business overview
    - Products offered
    - Recent developments
    MICREL MEDICAL DEVICES SA
    - Business overview
    - Products offered
    ZYNEX, INC.
    - Business overview
    - Products offered
    ENOVIS CORPORATION
    - Business overview
    - Products offered
  • 12.2 OTHER PLAYERS
    EPIC MEDICAL
    SOTERIX MEDICAL INC.
    GIMER MEDICAL
    NEURONANO AB
    ICECURE MEDICAL
    BIOWAVE
    THERANICA BIO-ELECTRONICS LTD.
APPENDIX
290
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD EXCHANGE RATES
  • TABLE 2 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 3 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 4 IMPACT OF PORTER’S FIVE FORCES
  • TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES
  • TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 7 US: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 8 CANADA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 9 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 11 BRAZIL: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 12 MEXICO: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 PATENT ANALYSIS, 2023–2024
  • TABLE 19 INDICATIVE PRICING OF PAIN MANAGEMENT DEVICES, BY REGION, 2023 (USD)
  • TABLE 20 KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
  • TABLE 22 KEY BUYING CRITERIA, BY TYPE
  • TABLE 23 ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 24 CELIAC PLEXUS CRYO-NEUROLYSIS FOR PALLIATIVE PAIN MANAGEMENT IN PANCREATIC CANCER
  • TABLE 25 GET READY REMOTE PATIENT MANAGEMENT SOLUTION FOR TIMELY CHRONIC PAIN TREATMENT OF
  • TABLE 26 MEDICARE CODING AND NATIONAL PAYMENT RATES FOR RADIOFREQUENCY ABLATION (SACROILIAC JOINT) PROCEDURES
  • TABLE 27 MEDICARE CODING AND NATIONAL PHYSICIAN PAYMENT RATES FOR SPINAL CORD STIMULATION PROCEDURES
  • TABLE 28 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 29 NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 30 NEUROSTIMULATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 OTHER NEUROSTIMULATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 35 INFUSION PUMPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 INTRATHECAL INFUSION PUMPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 EXTERNAL INFUSION PUMPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 39 ABLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 RF ABLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 CRYOABLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 OTHER ABLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 45 NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 CANCER PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 OTHER PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 51 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 54 PAIN MANAGEMENT DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 PAIN MANAGEMENT DEVICES MARKET FOR PHYSIOTHERAPY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 PAIN MANAGEMENT DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 PAIN MANAGEMENT DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: KEY MACRO INDICATORS
  • TABLE 68 US: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 69 US: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 70 US: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 71 US: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 72 US: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 73 US: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 74 US: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 75 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 CANADA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 77 CANADA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 CANADA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 80 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 81 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 82 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 EUROPE: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 85 EUROPE: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 EUROPE: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 89 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 90 EUROPE: KEY MACRO INDICATORS
  • TABLE 91 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 GERMANY: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 GERMANY: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 GERMANY: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 96 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 97 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 98 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 FRANCE: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 FRANCE: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 FRANCE: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 103 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 104 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 105 UK: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 UK: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 UK: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 UK: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 UK: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 110 UK: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 111 UK: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 112 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 ITALY: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 ITALY: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 ITALY: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 117 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 118 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 119 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 SPAIN: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 SPAIN: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 SPAIN: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 124 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 125 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 126 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 REST OF EUROPE: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 REST OF EUROPE: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 REST OF EUROPE: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 131 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 132 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: KEY MACRO INDICATORS
  • TABLE 142 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 JAPAN: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 JAPAN: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 JAPAN: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 147 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 148 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 149 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 CHINA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 CHINA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 CHINA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 154 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 155 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 156 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 INDIA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 INDIA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 INDIA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 161 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 162 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 163 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 AUSTRALIA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 AUSTRALIA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 AUSTRALIA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 168 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 169 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 170 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 SOUTH KOREA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 SOUTH KOREA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 SOUTH KOREA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 175 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 176 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 184 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 LATIN AMERICA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 190 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: KEY MACRO INDICATORS
  • TABLE 193 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 BRAZIL: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 BRAZIL: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 BRAZIL: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 198 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 199 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 200 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 MEXICO: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 MEXICO: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 MEXICO: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 205 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 206 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 207 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 REST OF LATIN AMERICA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: KEY MACRO INDICATORS
  • TABLE 223 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 GCC COUNTRIES NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 230 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 REST OF MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 REST OF MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 REST OF MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 235 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022–2029 (USD MILLION)
  • TABLE 236 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 237 PAIN MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 238 TYPE FOOTPRINT
  • TABLE 239 REGION FOOTPRINT
  • TABLE 240 LIST OF START-UPS/SMES
  • TABLE 241 COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 242 PAIN MANAGEMENT DEVICES MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 243 PAIN MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 244 PAIN MANAGEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 245 PAIN MANAGEMENT DEVICES MARKET: OTHERS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 246 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 247 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 248 MEDTRONIC: PRODUCT APPROVALS/LAUNCHES
  • TABLE 249 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 250 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 251 BOSTON SCIENTIFIC CORPORATION: DEALS
  • TABLE 252 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 253 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 254 ABBOTT LABORATORIES: PRODUCT LUNCHES/APPROVALS
  • TABLE 255 NEVRO CORP.: COMPANY OVERVIEW
  • TABLE 256 NEVRO CORP: PRODUCTS OFFERED
  • TABLE 257 NEVRO CORP.: PRODUCT APPROVALS/LAUNCHES
  • TABLE 258 NEVRO CORP.: DEALS, JANUARY 2021− SEPTEMBER 2024
  • TABLE 259 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 260 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 261 BECTON, DICKINSON AND COMPANY: OTHERS
  • TABLE 262 STRYKER: COMPANY OVERVIEW
  • TABLE 263 STRYKER: PRODUCTS OFFERED
  • TABLE 264 STRYKER: EXPANSIONS
  • TABLE 265 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 266 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 267 B. BRAUN SE: DEALS
  • TABLE 268 B. BRAUN SE: OTHERS
  • TABLE 269 BAXTER: COMPANY OVERVIEW
  • TABLE 270 BAXTER: PRODUCTS OFFERED
  • TABLE 271 OMRON CORPORATION: COMPANY OVERVIEW
  • TABLE 272 OMRON CORPORATION: PRODUCTS OFFERED
  • TABLE 273 AVANOS MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 274 AVANOS MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 275 AVANOS MEDICAL, INC.: DEALS
  • TABLE 276 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 277 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 278 ICU MEDICAL, INC.:COMPANY OVERVIEW
  • TABLE 279 ICU MEDICAL: PRODUCTS OFFERED
  • TABLE 280 ICU MEDICAL: DEALS
  • TABLE 281 NIPRO: COMPANY OVERVIEW
  • TABLE 282 NIPRO: PRODUCTS OFFERED
  • TABLE 283 NIPRO: EXPANSIONS
  • TABLE 284 MOOG INC.: COMPANY OVERVIEW
  • TABLE 285 MOOG INC.: PRODUCTS OFFERED
  • TABLE 286 ATRICURE, INC.: COMPANY OVERVIEW
  • TABLE 287 ATRICURE, INC.: PRODUCTS OFFERED
  • TABLE 288 ATRICURE, INC.: PRODUCT APPROVALS/ LAUNCHES
  • TABLE 289 MICREL MEDICAL DEVICES SA: COMPANY OVERVIEW
  • TABLE 290 MICREL MEDICAL DEVICES SA: PRODUCTS OFFERED
  • TABLE 291 ZYNEX, INC.: COMPANY OVERVIEW
  • TABLE 292 ZYNEX, INC: PRODUCTS OFFERED
  • TABLE 293 ENOVIS CORPORATION: COMPANY OVERVIEW
  • TABLE 294 ENOVIS CORPORATION: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC
  • FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 5 TOP-DOWN APPROACH
  • FIGURE 6 DATA TRIANGULATION
  • FIGURE 7 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 8 NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 INFUSION PUMPS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 ABLATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 PAIN MANAGEMENT DEVICES MARKET, BY REGION
  • FIGURE 15 GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG GERIATRIC POPULATION TO DRIVE MARKET
  • FIGURE 16 NEUROPATHIC PAIN AND CHINA TO BE MAJOR STAKEHOLDERS IN 2023
  • FIGURE 17 CHINA TO FASTEST-GROWING MARKET FOR PAIN MANAGEMENT DEVICES DURING FORECAST PERIOD
  • FIGURE 18 PAIN MANAGEMENT DEVICES MARKET DYNAMICS
  • FIGURE 19 SUPPLY CHAIN ANALYSIS
  • FIGURE 20 PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 21 PRE-MARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
  • FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 24 LATIN AMERICA: REGULATORY SCENARIO
  • FIGURE 25 BRAZIL: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 26 MEXICO: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 27 PATENT ANALYSIS, 2014–2024
  • FIGURE 28 GLOBAL PATENT APPLICATIONS, 2014–2024
  • FIGURE 29 INDICATIVE PRICING OF PAIN MANAGEMENT DEVICES, BY TYPE, 2023 (USD)
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE
  • FIGURE 31 KEY BUYING CRITERIA, BY TYPE
  • FIGURE 32 ECOSYSTEM ANALYSIS
  • FIGURE 33 VALUE CHAIN ANALYSIS
  • FIGURE 34 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 35 INVESTMENT AND FUNDING SCENARIO, 2019–2023
  • FIGURE 36 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 38 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024
  • FIGURE 39 REVENUE ANALYSIS OF TOP THREE PLAYERS, 2021–2023
  • FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 41 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 42 COMPANY FOOTPRINT
  • FIGURE 43 COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 44 BRAND/PRODUCT COMPARISON
  • FIGURE 45 R&D EXPENDITURE OF KEY PLAYERS, 2021–2023
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 49 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 51 NEVRO CORP.: COMPANY SNAPSHOT
  • FIGURE 52 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 53 STRYKER: COMPANY SNAPSHOT
  • FIGURE 54 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 55 BAXTER: COMPANY SNAPSHOT
  • FIGURE 56 OMRON CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 58 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 59 ICU MEDICAL: COMPANY SNAPSHOT
  • FIGURE 60 NIPRO: COMPANY SNAPSHOT
  • FIGURE 61 MOOG INC.: COMPANY SNAPSHOT
  • FIGURE 62 ATRICURE, INC.: COMPANY SNAPSHOT
  • FIGURE 63 ZYNEX, INC.: COMPANY SNAPSHOT
  • FIGURE 64 ENOVIS CORPORATION: COMPANY SNAPSHOT

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Global Burden of Disease Study , International Diabetes Federation (IDF), and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global pain management devices market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the pain management devices market. The primary sources from the demand side include hospitals & clinics, physiotherapy clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global pain management devices market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global pain management devices market was split into various segments and sub-segments based on:

  • List of major players operating in the pain management devices  products market at the regional and/or country level
  • Product mapping of various pain management devices  manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from pain management devices(or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation

After arriving at the overall size of the global pain management devices market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions

Stakeholders

  • Medical device manufacturers and distributors
  • Pain management devices manufacturers
  • Infusion pump and related instrument manufacturing companies
  • Suppliers and distributors of pain management devices
  • Hospitals and ambulatory surgery centers
  • Clinics
  • Home healthcare agencies
  • Research and consulting firms
  • Contract manufacturing organizations
  • Venture capitalists

Report Objectives

  • To define, measure, and describe the global pain management devices market by type, application, mode of purchase ,end user, and region
  • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
  • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, and patent analysis
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically analyze the market structure, profile the key players in the global pain management devices market, and comprehensively analyze their core competencies
  • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the pain management devices market

Previous Versions of this Report

Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts to 2026

Report Code MD 4371
Published in Nov, 2021, By MarketsandMarkets™

Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts to 2026

Report Code MD 4371
Published in Jun, 2016, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Pain Management Devices Market

Martha

Jun, 2022

I need more details on how global key players are dominating the Pain Management Devices Market. Much Appreciated.

Jonathan

Jun, 2022

What are the recent developments in the Global Pain Management Devices Market?.

DMCA.com Protection Status